Cancer and Context
癌症与背景
基本信息
- 批准号:9982211
- 负责人:
- 金额:$ 93.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:BreastBreast Cancer CellBreast Epithelial CellsCatalogingCatalogsCellsClustered Regularly Interspaced Short Palindromic RepeatsComputer AnalysisCoupledDiseaseEnvironmentEpithelialEpithelial CellsEpitheliumGenesGoalsHumanIn SituMalignant NeoplasmsMechanicsMethodsMitotic spindleMusMutationMyoepithelial cellNeoplasm MetastasisOncogenicOrganoidsPhenocopyPhenotypeProliferatingRoleSignal TransductionSiteStem cell transplantStructureSystemTechnologyTissuesTumor PromotersTumor SuppressionTumor Suppressor ProteinsUrsidae Familyanticancer researchcancer cellcancer initiationcell behaviorcell transformationcell typegene functionmalignant breast neoplasmmammary epitheliummammary gland developmentprogenitorpublic health relevanceresponsetumor initiationtumorigenesistumorigenic
项目摘要
DESCRIPTION (provided by applicant): Although cancer is caused by mutations in tumor suppressor and promoter genes, it is also a disease of cell behavior and cell context. The same mutations that cause transformation in one cell type are often tolerated in others and, conversely, wild type cells can phenocopy tumorigenic cells in a permissive environment. The reasons are not fully understood. However, one likely explanation is that homeostatic mechanisms in epithelia can suppress the tumorigenic phenotype. For example, if normal epithelial cells suppress proliferation of their neighbors, transformed cells might be unable to express their oncogenic potential unless they escape from the epithelial environment. We argue, therefore, that beyond the identification and cataloguing of mutations in human cancers, there is a pressing need to understand how cell context determines the responses to such mutations. Since most human cancers arise from epithelial cells or their progenitors, our over-arching goal is to determine how epithelial homeostatic mechanisms can suppress tumorigenesis, with a focus on breast cancer. We propose that transformed cells need to escape the suppressive signals generated by normal epithelial neighbors and that this is a key initiating step in tumorigenesis. How cells escape the epithelium and proliferate in ectopic sites is central to understanding cancer initiation and metastasis. Our previous studies, particularly over the last decade, have equipped us to make unique contributions to this field of cancer research. We developed a lentiviral transduction/stem cell transplantation method to study gene function in mouse mammary gland development and cancer, and developed a human organotypic culture system for breast organoids that matches in situ structures at the cellular and tissue levels with very high fidelity. These approaches, together with CRISPR gene editing technology, will be used to determine the roles of mitotic spindle mis-orientation in cancer initiation, tumor suppression by myoepithelial cells, and the subversion of mechanical tension signaling by breast cancer cells. We also collaborate with an experimental systems biologist who will use global, high-content analysis of signaling networks coupled with computational analysis, to identify key nodes that respond to homeostatic mechanisms in mammary epithelial cells. We predict that tumor initiation involves the constitutive activation of these nodes. Overal, this proposal brings multiple, state-of-the-art approaches to bear on a fundamental problem in cancer research, to understand how cell context determines phenotype.
描述(由适用提供):尽管癌症是由肿瘤抑制因子和启动子基因突变引起的,但它也是细胞行为和细胞环境的疾病。在另一种细胞类型中引起转化的相同突变通常在其他细胞类型中耐受性,相反,野生型细胞可以在宽松的环境中表现性结核细胞。原因尚未完全理解。但是,一个可能的解释是,上皮脑的稳态机制可以抑制肿瘤的表型。例如,如果正常的上皮细胞抑制其邻居的增殖,则经过转化的细胞可能无法表达其致癌潜力,除非它们从上皮环境中逃脱。因此,我们认为,除了对人类癌症中突变的识别和分类之外,还需要了解细胞环境如何确定对这种突变的反应。由于大多数人类癌症是由上皮细胞或其祖细胞引起的,因此我们的架构目标是确定上皮稳态机制如何抑制肿瘤发生,重点是乳腺癌。我们建议转化的细胞需要逃避正常上皮邻居产生的抑制信号,这是肿瘤发生的关键启动步骤。细胞如何逃脱上皮并在生态部位增殖是了解癌症倡议和转移的核心。我们以前的研究,尤其是在过去十年中,我们使我们为这一癌症研究领域做出了独特的贡献。我们开发了一种慢病毒转导/干细胞移植方法来研究小鼠乳腺发育和癌症中的基因功能,并开发了一种人类的器官培养系统,用于乳腺癌,该系统与非常高的富裕性的细胞和组织水平上的原位结构相匹配。这些方法以及CRISPR基因编辑技术将用于确定有丝分裂纺锤体错误定位在癌症启动中的作用,肌上皮细胞抑制肿瘤以及乳腺癌细胞对机械张力信号的颠覆。我们还与一个实验系统生物学家合作,该实验系统将对信号网络的全球高含量分析以及计算分析,以识别对乳腺上皮细胞中稳态机制做出反应的关键节点。我们预测肿瘤感染涉及这些节点的本构激活。该提案过于多,带来了多种最先进的方法来解决癌症研究中的基本问题,以了解细胞环境如何决定表型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IAN G MACARA其他文献
IAN G MACARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IAN G MACARA', 18)}}的其他基金
相似国自然基金
靶向SIRT3小分子激动剂调控三阴性乳腺癌细胞自噬和免疫微环境的机制研究
- 批准号:82373193
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
EZH2巴豆酰化修饰抑制乳腺癌细胞转移的作用和机制研究
- 批准号:82372992
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于脂肪细胞对乳腺癌细胞的代谢重编程作用探讨3-羟基丁酰化修饰调控三阴性乳腺癌化疗敏感性的机制
- 批准号:82303592
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FAD合成酶通过调控线粒体氧化磷酸化影响三阴性乳腺癌细胞衰老的作用及机制研究
- 批准号:82303048
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
毛枝卷柏Robustaflavone A调控糖酵解介导乳腺癌细胞铁死亡机制研究
- 批准号:82304794
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of ceramide kinase in metastasis growth from aggressive breast cancer
神经酰胺激酶在侵袭性乳腺癌转移生长中的作用
- 批准号:
10652894 - 财政年份:2023
- 资助金额:
$ 93.99万 - 项目类别:
Engineered hybrid aging model for disease progression
用于疾病进展的工程混合衰老模型
- 批准号:
10608767 - 财政年份:2023
- 资助金额:
$ 93.99万 - 项目类别:
Targeting the HMGB1-TLR5 pathway to prevent senescence-induced metastasis in breast cancer.
靶向 HMGB1-TLR5 通路预防乳腺癌衰老诱导的转移。
- 批准号:
10599637 - 财政年份:2023
- 资助金额:
$ 93.99万 - 项目类别:
The Role of EpCAM Glycosylation in Breast Cancer Metastasis
EpCAM 糖基化在乳腺癌转移中的作用
- 批准号:
10605857 - 财政年份:2023
- 资助金额:
$ 93.99万 - 项目类别:
PDGF-BB and the metastatic brain microenvironment
PDGF-BB和转移性脑微环境
- 批准号:
10718597 - 财政年份:2023
- 资助金额:
$ 93.99万 - 项目类别: